Prestige Consumer Healthcare (PBH) Goodwill & Intangibles (2011 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Goodwill & Intangibles came in at $2.9 billion in Q4 2025, up 1.58% year-on-year from $2.8 billion in Q4 2024, and up 2.25% quarter-over-quarter from $2.8 billion in Q3 2025.
Prestige Consumer Healthcare (PBH) Goodwill & Intangibles (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Goodwill & Intangibles history runs 15 years deep, the most recent figure standing at $2.9 billion for Q4 2025.
- On a quarterly basis, Goodwill & Intangibles rose 1.58% year-over-year to $2.9 billion in Q4 2025; TTM through Dec 2025 was $2.9 billion, a 1.58% increase from a year earlier, with the FY2025 full-year figure at $2.8 billion, down 0.9% from the prior year.
- Goodwill & Intangibles improved to $2.9 billion in Q4 2025 per PBH's latest filing, from $2.8 billion in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $3.3 billion in Q4 2021 and bottomed at $2.8 billion in Q3 2025.
- The 5-year median for Goodwill & Intangibles is $2.9 billion (2023), against an average of $3.0 billion.
- Across the five-year window, Goodwill & Intangibles increased 7.26% in 2022 and dropped 12.4% in 2023, its largest moves.
- Year by year, Goodwill & Intangibles stood at $3.3 billion in 2021, then fell by 1.09% to $3.2 billion in 2022, then decreased by 12.03% to $2.9 billion in 2023, then retreated by 0.65% to $2.8 billion in 2024, then advanced by 1.58% to $2.9 billion in 2025.
- Per Business Quant, the three latest PBH Goodwill & Intangibles figures stand at $2.9 billion (Q4 2025), $2.8 billion (Q3 2025), and $2.8 billion (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.13 Bn | 20.97 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.88 Bn |
| Sep 30, 2025 | 2.82 Bn |
| Jun 30, 2025 | 2.82 Bn |
| Mar 31, 2025 | 2.82 Bn |
| Dec 31, 2024 | 2.84 Bn |
| Sep 30, 2024 | 2.85 Bn |
| Jun 30, 2024 | 2.85 Bn |
| Mar 31, 2024 | 2.85 Bn |
| Dec 31, 2023 | 2.86 Bn |
| Sep 30, 2023 | 2.86 Bn |
| Jun 30, 2023 | 2.86 Bn |
| Mar 31, 2023 | 2.87 Bn |
| Dec 31, 2022 | 3.25 Bn |
| Sep 30, 2022 | 3.25 Bn |
| Jun 30, 2022 | 3.26 Bn |
| Mar 31, 2022 | 3.28 Bn |
| Dec 31, 2021 | 3.28 Bn |
| Sep 30, 2021 | 3.27 Bn |
| Jun 30, 2021 | 3.05 Bn |
| Mar 31, 2021 | 3.05 Bn |